BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31712618)

  • 21. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
    MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
    BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of autonomous activity of Ca(2+)/calmodulin-dependent protein kinase kinase β by autophosphorylation.
    Tokumitsu H; Hatano N; Fujimoto T; Yurimoto S; Kobayashi R
    Biochemistry; 2011 Sep; 50(38):8193-201. PubMed ID: 21859090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGFBP-2 stimulates calcium/calmodulin-dependent protein kinase kinase 2 activation leading to AMP-activated protein kinase induction which is required for osteoblast differentiation.
    Xi G; D'Costa S; Wai C; Xia SK; Cox ZC; Clemmons DR
    J Cell Physiol; 2019 Dec; 234(12):23232-23242. PubMed ID: 31155724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes.
    Shen QW; Zhu MJ; Tong J; Ren J; Du M
    Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1395-403. PubMed ID: 17687000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research Resource: Roles for Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Systems Metabolism.
    Marcelo KL; Ribar T; Means CR; Tsimelzon A; Stevens RD; Ilkayeva O; Bain JR; Hilsenbeck SG; Newgard CB; Means AR; York B
    Mol Endocrinol; 2016 May; 30(5):557-72. PubMed ID: 27003444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.
    Subbannayya Y; Syed N; Barbhuiya MA; Raja R; Marimuthu A; Sahasrabuddhe N; Pinto SM; Manda SS; Renuse S; Manju HC; Zameer MA; Sharma J; Brait M; Srikumar K; Roa JC; Vijaya Kumar M; Kumar KV; Prasad TS; Ramaswamy G; Kumar RV; Pandey A; Gowda H; Chatterjee A
    Cancer Biol Ther; 2015; 16(2):336-45. PubMed ID: 25756516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD.
    York B; Li F; Lin F; Marcelo KL; Mao J; Dean A; Gonzales N; Gooden D; Maity S; Coarfa C; Putluri N; Means AR
    Sci Rep; 2017 Sep; 7(1):11793. PubMed ID: 28924233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A complete map of the Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) signaling pathway.
    Najar MA; Rex DAB; Modi PK; Agarwal N; Dagamajalu S; Karthikkeyan G; Vijayakumar M; Chatterjee A; Sankar U; Prasad TSK
    J Cell Commun Signal; 2021 Jun; 15(2):283-290. PubMed ID: 33136287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model.
    Price DJ; Drewry DH; Schaller LT; Thompson BD; Reid PR; Maloney PR; Liang X; Banker P; Buckholz RG; Selley PK; McDonald OB; Smith JL; Shearer TW; Cox RF; Williams SP; Reid RA; Tacconi S; Faggioni F; Piubelli C; Sartori I; Tessari M; Wang TY
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1958-1963. PubMed ID: 29653895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the aryl hydrocarbon receptor by the calcium/calmodulin-dependent protein kinase kinase inhibitor 7-oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid (STO-609).
    Monteiro P; Gilot D; Langouet S; Fardel O
    Drug Metab Dispos; 2008 Dec; 36(12):2556-63. PubMed ID: 18755850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Data for the co-expression and purification of human recombinant CaMKK2 in complex with calmodulin in Escherichia coli.
    Gerner L; Munack S; Temmerman K; Lawrence-Dörner AM; Besir H; Wilmanns M; Jensen JK; Thiede B; Mills IG; Morth JP
    Data Brief; 2016 Sep; 8():733-40. PubMed ID: 27508226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Distinct Roles of CaMKK Isoforms Using STO-609-Resistant Mutants in Living Cells.
    Fujiwara Y; Hiraoka Y; Fujimoto T; Kanayama N; Magari M; Tokumitsu H
    Biochemistry; 2015 Jun; 54(25):3969-77. PubMed ID: 26050738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-9 attenuates amyloidβ-induced synaptotoxicity by targeting calcium/calmodulin-dependent protein kinase kinase 2.
    Chang F; Zhang LH; Xu WP; Jing P; Zhan PY
    Mol Med Rep; 2014 May; 9(5):1917-22. PubMed ID: 24603903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2.
    Meirson T; Samson AO; Gil-Henn H
    Drug Des Devel Ther; 2017; 11():1535-1557. PubMed ID: 28572720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction.
    Jensen TE; Rose AJ; Jørgensen SB; Brandt N; Schjerling P; Wojtaszewski JF; Richter EA
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1308-17. PubMed ID: 17213473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells.
    Karacosta LG; Kuroski LA; Hofmann WA; Azabdaftari G; Mastri M; Gocher AM; Dai S; Hoste AJ; Edelman AM
    Prostate; 2016 Feb; 76(3):294-306. PubMed ID: 26552607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The camKK2/camKIV relay is an essential regulator of hepatic cancer.
    Lin F; Marcelo KL; Rajapakshe K; Coarfa C; Dean A; Wilganowski N; Robinson H; Sevick E; Bissig KD; Goldie LC; Means AR; York B
    Hepatology; 2015 Aug; 62(2):505-20. PubMed ID: 25847065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CAMKK2-CAMK4 signaling regulates transferrin trafficking, turnover, and iron homeostasis.
    Sabbir MG
    Cell Commun Signal; 2020 May; 18(1):80. PubMed ID: 32460794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
    Popovics P; Frigo DE; Schally AV; Rick FG
    Expert Opin Ther Targets; 2015 May; 19(5):617-32. PubMed ID: 25600663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Characterization of Novel Molecular Probes for Ca
    Ohtsuka S; Ozeki Y; Fujiwara M; Miyagawa T; Kanayama N; Magari M; Hatano N; Suizu F; Ishikawa T; Tokumitsu H
    Biochemistry; 2020 May; 59(17):1701-1710. PubMed ID: 32298102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.